Dnca Finance Has $18.56 Million Position in Synopsys, Inc. $SNPS

Dnca Finance lessened its position in Synopsys, Inc. (NASDAQ:SNPS) by 6.7% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 36,210 shares of the semiconductor company’s stock after selling 2,590 shares during the period. Synopsys comprises approximately 1.4% of Dnca Finance’s holdings, making the stock its 23rd biggest holding. Dnca Finance’s holdings in Synopsys were worth $18,564,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Lionshead Wealth Management LLC boosted its position in Synopsys by 1.9% in the second quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock valued at $469,000 after buying an additional 17 shares in the last quarter. YANKCOM Partnership raised its stake in shares of Synopsys by 3.3% in the second quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock valued at $275,000 after acquiring an additional 17 shares during the last quarter. Manchester Capital Management LLC boosted its holdings in shares of Synopsys by 5.3% in the 2nd quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock worth $174,000 after acquiring an additional 17 shares in the last quarter. Hemington Wealth Management boosted its holdings in shares of Synopsys by 10.1% in the 2nd quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock worth $100,000 after acquiring an additional 18 shares in the last quarter. Finally, Concord Asset Management LLC VA grew its position in Synopsys by 0.8% during the 2nd quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock worth $1,220,000 after acquiring an additional 18 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.

Synopsys Stock Performance

Synopsys stock opened at $466.76 on Friday. The company has a market cap of $86.70 billion, a PE ratio of 36.64, a PEG ratio of 5.35 and a beta of 1.16. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company’s 50-day moving average is $437.04 and its two-hundred day moving average is $505.35.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same quarter in the prior year, the firm earned $3.43 EPS. The firm’s quarterly revenue was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS and its Q4 2025 guidance at 2.760-2.80 EPS. Equities analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Needham & Company LLC reduced their price objective on Synopsys from $660.00 to $550.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Wall Street Zen downgraded shares of Synopsys from a “hold” rating to a “sell” rating in a research report on Saturday, September 13th. BNP Paribas assumed coverage on shares of Synopsys in a report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price objective on the stock. JPMorgan Chase & Co. dropped their target price on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating for the company in a research note on Wednesday, September 10th. Finally, Robert W. Baird reissued a “neutral” rating and set a $535.00 price target (down from $670.00) on shares of Synopsys in a research note on Wednesday, September 10th. Ten analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $555.33.

Insider Buying and Selling at Synopsys

In related news, Director Robert G. Painter acquired 350 shares of the company’s stock in a transaction that occurred on Thursday, September 11th. The stock was acquired at an average price of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the acquisition, the director owned 2,291 shares of the company’s stock, valued at $974,683.04. This trade represents a 18.03% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the completion of the transaction, the chief accounting officer directly owned 20,520 shares in the company, valued at $10,278,468. The trade was a 32.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.62% of the company’s stock.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.